董事會會議通告 香港交易及結算所有限公司及香港聯合交易所有限公司對本通告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不會就本通告全部或任何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 UNQ HOLDINGS LIMITED 优趣汇控股有限公司 ( 於開曼群島註冊成立的有限公司 ) (股份代號：2177) 优趣汇控股有限公司（「本公司」）董事會（「董事會」）謹此宣佈，本公司將於 二零二五年八月二十九日(星期五)舉行董事會會議，藉以(其中包括)考慮及批准本 公司及其附屬公司截至二零二五年六月三十日止六個月之中期業績及其發佈，並 考慮派發中期股息 (如有)，及處理其他事項。 承董事會命 优趣汇控股有限公司 王勇 主席 香港，二零二五年八月十八日 於本通告日期，本公司執行董事為王勇先生、沈宇先生及陳偉偉女士；本公司非執 行董事為中山國慶先生；而本公司獨立非執行董事為吳錦華先生、魏航先生及辛洪 華女士。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 优趣汇控股有限公司 呈交日期: 2025年8月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02177 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 3,800,000,000 | | HKD | | 0.0001 HKD | | 380,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 3,800,000,000 | HKD | | 0.0001 HKD | | 380,000 | 本月底法定/註冊股本總額： HKD 380,000 F ...

Group 1 - Company YQH was awarded the title of "2025 New Quality Productivity Leading Enterprise" at the 14th CFS Finance Summit, and its CFO, Mr. Shen Yu, received the "2025 Outstanding Influence CFO" award, highlighting its leadership in digital brand operations [1][3] - The CFS Finance Summit, established in 2012, focused on new quality productivity, technological innovation, digitalization, artificial intelligence, and other key areas, with over 1,000 representatives from various sectors attending [3] - YQH has invested several million in R&D over 15 years, serving over 200 international brands across various categories, and has implemented a self-developed AI model for full-chain digital upgrades [3][4] Group 2 - In 2024, YQH's "AI + Supply Chain" solutions helped partner brands reduce average inventory turnover days and logistics costs, leading to its recognition as a "Shanghai New Quality E-commerce Enterprise" [4] - CFO Shen Yu has driven financial agility through the introduction of AI tools, optimizing capital structure, and achieving a reduction in overall financing costs, while also leading the ESG metrics system [4] - The company aims to leverage its recent awards as a new impetus to enhance industry standards, user experience, and green value creation, focusing on user-centric innovation [5]

Group 1: Stock Movements in Hong Kong Market - Youqu Holdings (02177) surged over 24% as it actively expands into the health sector with the launch of the Canadian anti-aging health food brand Vanpearl containing ergothioneine [1] - Longfly Fiber Optics (06869) rose nearly 10% following the commencement of mass production at its advanced Wuhan base, successfully producing its first 6-inch silicon carbide wafer [1] - SF Holding (06936) increased over 5% with a reported 19.1% year-on-year growth in express delivery volume in April 2025, reaching 16.32 billion parcels [1] Group 2: Notable Developments in Other Companies - Alibaba Pictures (01060) gained over 4% after announcing a name change to Damai Entertainment, indicating a focus on offline performances and IP derivatives [2] - Innovent Biologics (01801) rose over 4% after presenting promising results for its innovative drug IBI343 for treating advanced pancreatic cancer at the 2025 ASCO annual meeting [2] - Ideal Auto (02015) saw a rise of over 6% with May deliveries reaching 40,856 units, marking a 16.7% year-on-year increase [4] Group 3: U.S. Market Highlights - Ferguson (FERG.US) increased by 2.9% with Q3 sales of $7.621 billion, a 4.3% year-on-year growth, exceeding market expectations [5] - Credo Technology (CRDO.US) surged over 14% with Q4 revenue of $170.3 million, a 179.7% year-on-year increase [6] - Nvidia (NVDA.US) rose by 2.8% as UBS projected significant revenue from a new AI data center project in Texas [6]

Core Viewpoint - The stock price of Youqu Holdings has surged over 140% since the end of March, indicating a strong market interest and a potential recovery from previous low performance levels [2][3]. Group 1: Company Overview - Youqu Holdings focuses on brand e-commerce operations, providing comprehensive solutions to enhance sales growth and market expansion for various brands [2]. - The company collaborates with approximately 60 brands, including major names in the fast-moving consumer goods sector such as Unicharm, Kose, and others [4]. Group 2: Financial Performance - In 2024, Youqu Holdings reported a revenue of 1.348 billion RMB, a decrease of 22.3% year-on-year, attributed to a strategic shift away from low-margin businesses [4]. - The overall gross margin for 2024 reached 30.0%, an increase of 3.7 percentage points from the previous year, with a net profit of 36.471 million RMB, marking a significant turnaround from losses [5]. Group 3: Strategic Initiatives - The company launched the Canadian health food brand Vanpearl, which focuses on anti-aging products containing ergothioneine, leveraging its established e-commerce capabilities to penetrate the Chinese market [6][7]. - The entry into the ergothioneine market is seen as a strategic move to tap into a high-potential sector, reflecting the company's operational experience in the health industry [7].

Group 1 - As of June 3, a total of 105 stocks reached their 52-week highs, with Huayin International Holdings (00989), Dingyifeng Holdings (00612), and Youquhui Holdings (02177) leading the high rate at 57.26%, 37.93%, and 23.02% respectively [1] - The closing prices and highest prices for the top three stocks are as follows: Huayin International Holdings at 1.370 and 1.950, Dingyifeng Holdings at 0.770 and 0.800, and Youquhui Holdings at 3.550 and 3.580 [1] - Other notable stocks that reached their 52-week highs include China Antibody-B (03681) with a high rate of 21.62% and Fengcheng Holdings (02295) at 19.52% [1] Group 2 - The report also lists stocks that reached their 52-week lows, with Des Holdings (08437) showing the largest decline at -38.79%, followed by Dimi Life Holdings (01667) at -20.50% [3] - The closing prices and lowest prices for the top three stocks that reached their lows are: Des Holdings at 0.177 and 0.071, Dimi Life Holdings at 0.140 and 0.128, and Lujizhi Technology (01745) at 0.197 and 0.194 [3] - Other stocks with significant declines include GBA Group (00261) at -11.48% and Baide International (02668) at -10.88% [3]

Company Overview - Youquhui Holdings Limited is a leading brand e-commerce operation service provider in China, focusing on beauty products, personal care, health products, and daily necessities [2] - The company provides comprehensive, multi-dimensional, and customized services for major brands, maximizing brand influence and potential [2] - Youquhui aims to meet the increasingly diverse needs of consumers and is committed to creating higher social value [2] Financial Performance - As of December 31, 2024, Youquhui achieved total operating revenue of 1.348 billion yuan, a year-on-year decrease of 22.32% [1] - The net profit attributable to the parent company was 37.892 million yuan, a year-on-year increase of 308% [1] - The gross profit margin stood at 30.01%, and the debt-to-asset ratio was 39.45% [1] Stock Performance - As of June 3, the stock price of Youquhui Holdings closed at 3.55 HKD per share, an increase of 24.13% [1] - Over the past month, the stock has seen a cumulative increase of 22.75%, and a year-to-date increase of 104.29%, outperforming the Hang Seng Index by 15.44% [1] - Currently, there are no institutional investment ratings for the stock [1] Industry Valuation - The average price-to-earnings (P/E) ratio for the professional retail industry (TTM) is 4.76 times, with a median of -0.27 times [1] - Youquhui's P/E ratio is 11.6 times, ranking 15th in the industry [1] - Comparatively, other companies in the industry have the following P/E ratios: Baoguang Industrial at 0.18 times, Chen Chang International at 4.49 times, and others [1]

Core Viewpoint - The article emphasizes the importance of proactive strategies for companies in the e-commerce operation industry, particularly in the context of the evolving market landscape and the need for diversification into new sectors like health and wellness [1][3]. Group 1: Industry Context - The e-commerce operation industry is facing increased complexity as the market reaches saturation and consumer spending is still recovering [1]. - The health and wellness market, particularly anti-aging products, is projected to grow significantly, with the global anti-aging product market expected to reach $266.2 billion by 2024 and $498.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 8% [3][4]. Group 2: Company Strategy - UQH Holdings (优趣汇控股) has launched a Canadian anti-aging health food brand, Vanpearl, and appointed Barry Halliwell as Chief Scientist to strengthen its research capabilities in the health sector [2][4]. - The company has a history of collaboration with established Japanese pharmaceutical brands, which provides valuable operational experience for managing its own health food brand [3][4]. - UQH's Vanpearl brand has already achieved approximately $27 million in gross merchandise value (GMV) since the beginning of the year, indicating a strong market entry [5]. Group 3: Future Prospects - UQH aims to leverage the success of Vanpearl to establish a second growth curve in the health market, with plans for further brand acquisitions or launches [6]. - The company reported a 29.6% year-on-year increase in cash and cash equivalents, amounting to 440 million yuan, providing a solid financial foundation for future investments [6]. - A strategic partnership with a high-end probiotic brand, Puba™, is expected to enhance UQH's market presence in China, showcasing its operational strengths in e-commerce [6][7].

Company Overview - Youquhui Holdings Limited is a leading brand e-commerce operation service provider in China, focusing on beauty products, personal care, baby care, health products, and daily necessities [2] - The company provides comprehensive, multi-dimensional, and customized services for major brands, maximizing their influence and releasing brand potential [2] - Youquhui aims to meet the increasingly diverse needs of consumers and is committed to creating higher social value [2] Financial Performance - As of December 31, 2024, Youquhui achieved total revenue of 1.348 billion yuan, a year-on-year decrease of 22.32% [1] - The net profit attributable to shareholders was 37.892 million yuan, showing a significant year-on-year increase of 308% [1] - The gross profit margin stood at 30.01%, and the debt-to-asset ratio was 39.45% [1] Stock Performance - As of May 28, the stock price of Youquhui Holdings closed at 2.54 HKD per share, reflecting a rise of 14.41% [1] - Over the past month, the stock has seen a cumulative decline of 9.02%, while it has increased by 58.57% year-to-date, outperforming the Hang Seng Index by 16.56% [1] - Currently, there are no institutional investment ratings for the stock [1] Industry Valuation - The average price-to-earnings (P/E) ratio for the professional retail industry (TTM) is 4.69 times, with a median of -0.26 times [1] - Youquhui's P/E ratio is 9 times, ranking 13th in the industry [1] - Comparatively, other companies in the industry have the following P/E ratios: Baoguang Industrial at 0.18 times, Chen Chang International at 4.75 times, and others ranging from 5.29 to 6.41 times [1]

Core Insights - The strategic partnership between Youquhui (02177) and PrecisionBiotics aims to leverage Youquhui's brand operation expertise and PrecisionBiotics' advanced probiotic research to penetrate the Chinese health e-commerce market [1][4] - PrecisionBiotics, originating from University College Cork, Ireland, has 25 years of research in human microecology, focusing on effective probiotic solutions derived from natural human gut strains [4] - The collaboration will enhance PrecisionBiotics' market presence in China by utilizing Youquhui's experience in e-commerce operations, marketing, and supply chain management [4] Company Overview - Youquhui is positioned to integrate its operational strengths with PrecisionBiotics' scientific advancements to deliver scientifically-backed probiotic products to consumers [1] - PrecisionBiotics is recognized for its expertise in strain identification and gene expression analysis, ensuring the safety and efficacy of its probiotic products [4] Product Focus - The Alforex dual-effect probiotic product targets Irritable Bowel Syndrome (IBS) and combines scientifically validated strains to improve gut health and alleviate symptoms such as abdominal pain and bloating [4] - The product also contributes positively to stress relief, sleep aid, and emotional regulation [4]